Schrödinger (NasdaqGS:SDGR) Q1 2026 Earnings call May 05, 2026 04:30 PM ET Company ParticipantsJaren Madden - Chief Corporate Affairs Officer and Head of Investor RelationsKaren Akinsanya - President, Head of Therapeutics R&D, and Chief Strategy Officer of PartnershipsMichael Ryskin - Managing Director in Equity ResearchMichael Yee - Global Head of Biotechnology Equity ResearchPatrick Lorton - CTO and COORamy Farid - CEORichie Jain - CFOConference Call ParticipantsBrendan Smith - Director and Life Science a ...